{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-048277","form_type":"8-K","ticker":"ALLR","cik":"0001860657","company_name":"Allarity Therapeutics, Inc.","filed_at":"2026-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.167014+00:00","generated_at":"2026-05-15T03:11:29.810410+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Allarity Therapeutics receives USPTO Notice of Allowance for stenoparib DRP companion diagnostic patent","bullets":["Notice of Allowance covers multiple claims for methods predicting clinical benefit and patient selection via gene expression.","Patent expected to be granted within three months; would provide exclusivity at least into 2039 for stenoparib with DRP test.","Allarity previously secured European and Australian patents for Stenoparib DRP; holds 18 granted patents for other drug-specific DRPs.","Patent applications for Stenoparib DRP remain pending in Canada, Japan, China, and India."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-048277","json":"https://secwatch.observer/filing/0001213900-26-048277.json","markdown":"https://secwatch.observer/filing/0001213900-26-048277.md","text":"https://secwatch.observer/filing/0001213900-26-048277.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026048277/0001213900-26-048277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026048277/ea0287908-8k_allarity.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T03:11:29.810410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}